These IND/IDE services are intended to promote compliance with Food and Drug Administration (FDA) regulations in sponsor-investigator drug, device and biologics studies at the University of Minnesota. Sponsor-Investigators can receive guidance on pre-submission FDA interactions, IND and IDE submissions and associated reports to the FDA and the Institutional Review Board (IRB).
The following services are available upon request:
- Offer explanation of IND and IDE regulations
- Assist with requesting “not significant risk” (NSR) determinations
- Assist in understanding the obligations of a sponsor or a sponsor-investigator
- Assist in determining product classification, i.e., drug, device, biologic
- Assist in determining applicability of an IND or IDE
- Assist in determining contents of an IND or IDE
- Assist in submitting pre-IND/IDE, IND and IDE applications to the FDA
- Assist in scheduling, coordinating, preparing and attending meetings with the FDA
- Offer regulatory support for IRB applications
- Offer regulatory assistance during FDA inspections of investigator sponsored clinical trials
- Circulate periodic news items from FDA relating to sponsor-investigator clinical trials
To receive any of these services contact the HRPP at 612-626-5654 or email at [email protected]
Add new comment